FDA’s Regulatory Approach to CRISPR Technology

Time: 8:30 am
day: Day One

Details:

• FDA regulates human gene therapy in the United States
• CRISPR offers the opportunity to transform disease management
• Use of CRISPR constructs may also shift the focus of development of the current generation of gene therapy vectors
• FDA will continue to work with sponsors to expedite the development of novel cell and gene therapies

Speakers: